| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.493 | 0.037 | 0.493 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.368 0.131 CID_154699947 | ||
| 0.394 | 0.064 | 0.394 | GABA C receptor rho-3 antagonist | 0.215 0.189 CID_154699947 | ||
| 0.276 | 0.009 | 0.276 | Death-associated protein kinase 2 inhibitor | 0.17 0.069 CID_154699947 | ||
| 0.317 | 0.053 | 0.317 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.254 | 0.005 | 0.254 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.198 0.019 CID_154699947 | ||
| 0.249 | 0.014 | 0.249 | ATPase inhibitor | |||
| 0.23 | 0.013 | 0.23 | Aurora-C kinase inhibitor | 0.152 0.048 CID_154699947 | ||
| 0.22 | 0.008 | 0.22 | MAP kinase kinase 4 inhibitor | 0.187 0.019 CID_154699947 | ||
| 0.265 | 0.055 | 0.265 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.346 | 0.149 | 0.346 | Caspase 9 stimulant | |||
| 0.19 | 0.028 | 0.19 | MAP kinase 3 inhibitor | |||
| 0.218 | 0.065 | 0.218 | Death-associated protein kinase 3 inhibitor | |||
| 0.217 | 0.068 | 0.217 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.171 | 0.025 | 0.171 | Check point kinase 2 inhibitor | 0.083 0.081 CID_154699947 | ||
| 0.189 | 0.044 | 0.189 | Heat shock protein 90 antagonist | |||
| 0.177 | 0.038 | 0.177 | MAP kinase kinase inhibitor | |||
| 0.182 | 0.053 | 0.182 | Interleukin 6 antagonist | |||
| 0.292 | 0.164 | 0.292 | Calcium channel L-type activator | |||
| 0.174 | 0.045 | 0.174 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.208 | 0.087 | 0.208 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.199 | 0.081 | 0.199 | Pyruvate kinase inhibitor | 0.138 0.127 CID_154699947 | ||
| 0.181 | 0.065 | 0.181 | Peroxidase inhibitor | |||
| 0.175 | 0.066 | 0.175 | Heat shock protein 90 alpha antagonist | |||
| 0.14 | 0.032 | 0.14 | Transcription factor STAT6 inhibitor | |||
| 0.201 | 0.098 | 0.201 | Dyrk kinase inhibitor | |||
| 0.134 | 0.04 | 0.134 | GABA C receptor antagonist | 0.097 0.082 CID_154699947 | ||
| 0.162 | 0.069 | 0.162 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.142 | 0.054 | 0.142 | Death-associated protein kinase 1 inhibitor | |||
| 0.216 | 0.134 | 0.216 | Insulysin inhibitor | |||
| 0.152 | 0.071 | 0.152 | GABA C receptor rho-2 antagonist | |||
| 0.126 | 0.052 | 0.126 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.173 | 0.101 | 0.173 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.127 | 0.056 | 0.127 | Glycogen synthase kinase-3 inhibitor | |||
| 0.142 | 0.072 | 0.142 | MAP3K9 inhibitor | |||
| 0.172 | 0.102 | 0.172 | MAP kinase kinase 2 inhibitor | |||
| 0.091 | 0.023 | 0.091 | MAP kinase kinase 7 inhibitor | |||
| 0.075 | 0.009 | 0.075 | Thymidylate synthase inhibitor | |||
| 0.121 | 0.057 | 0.121 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.229 | 0.173 | 0.229 | Calcium channel activator | |||
| 0.193 | 0.144 | 0.193 | MAP kinase kinase 3 inhibitor | |||
| 0.136 | 0.088 | 0.136 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.05 | 0.011 | 0.05 | Histone deacetylase class II inhibitor | |||
| 0.053 | 0.015 | 0.053 | Histone deacetylase 5 inhibitor | |||
| 0.075 | 0.042 | 0.075 | I kappa B kinase 1 inhibitor | |||
| 0.105 | 0.073 | 0.105 | MAP kinase 13 inhibitor | |||
| 0.104 | 0.073 | 0.104 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.075 | 0.046 | 0.075 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.085 | 0.056 | 0.085 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.04 | 0.013 | 0.04 | Histone deacetylase class IIb inhibitor | |||
| 0.04 | 0.013 | 0.04 | Histone deacetylase 6 inhibitor | |||
| 0.059 | 0.033 | 0.059 | Cyclin B2 inhibitor | |||
| 0.168 | 0.142 | 0.168 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.164 | 0.14 | 0.164 | Tumour necrosis factor alpha release inhibitor | |||
| 0.041 | 0.017 | 0.041 | Histone deacetylase class IIa inhibitor | |||
| 0.069 | 0.048 | 0.069 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.062 | 0.042 | 0.062 | Cyclin B1 inhibitor | |||
| 0.057 | 0.037 | 0.057 | Phosphodiesterase 4C inhibitor | |||
| 0.056 | 0.037 | 0.056 | Immunoglobulin Fc receptor antagonist | |||
| 0.102 | 0.084 | 0.102 | Photosensitizer | |||
| 0.037 | 0.02 | 0.037 | Histone deacetylase 2 inhibitor | |||
| 0.065 | 0.05 | 0.065 | Cyclin B3 inhibitor | |||
| 0.08 | 0.065 | 0.08 | Transforming growth factor beta 3 antagonist | |||
| 0.125 | 0.111 | 0.125 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.105 | 0.091 | 0.105 | MAP kinase 12 inhibitor | |||
| 0.035 | 0.021 | 0.035 | ADAM10 endopeptidase inhibitor | |||
| 0.056 | 0.044 | 0.056 | Protein kinase C iota inhibitor | |||
| 0.052 | 0.041 | 0.052 | GABA receptor antagonist | |||
| 0.032 | 0.022 | 0.032 | Histone deacetylase 11 inhibitor | |||
| 0.032 | 0.022 | 0.032 | Histone deacetylase class IV inhibitor | |||
| 0.066 | 0.056 | 0.066 | Phosphodiesterase V inhibitor | |||
| 0.051 | 0.044 | 0.051 | Cyclin B inhibitor | |||
| 0.064 | 0.057 | 0.064 | Phosphodiesterase 5A inhibitor | |||
| 0.03 | 0.023 | 0.03 | Potassium channel small-conductance Ca-activated activator | |||
| 0.024 | 0.018 | 0.024 | Histone deacetylase 1 inhibitor | |||
| 0.027 | 0.022 | 0.027 | Histone deacetylase 10 inhibitor | |||
| 0.029 | 0.025 | 0.029 | Histone deacetylase 4 inhibitor | |||
| 0.062 | 0.06 | 0.062 | Janus tyrosine kinase 3 inhibitor | |||
| 0.12 | 0.118 | 0.12 | CDC-like kinase 2 inhibitor | |||
| 0.065 | 0.086 | 0.097 | Glycine receptor antagonist | 0.097 0.035 CID_154699947 | CID_154699947 | |
| 0.069 | 0.102 | 0.091 | Triose-phosphate isomerase inhibitor | 0.091 0.058 CID_154699947 | CID_154699947 | |
| 0.07 | 0.12 | 0.116 | Protein kinase C zeta inhibitor | 0.116 0.035 CID_154699947 | CID_154699947 | |
| 0.172 | 0.266 | 0.398 | Antibacterial | 0.398 0.078 CID_154699947 | CID_154699947 | |
| 0.145 | 0.297 | 0.224 | Histamine release inhibitor | 0.224 0.177 CID_154699947 | CID_154699947 | |
| 0.025 | 0.201 | 0.05 | Heparanase inhibitor | 0.05 0.044 CID_154699947 | CID_154699947 | |
| 0.108 | 0.333 | 0.186 | RNA-directed DNA polymerase inhibitor | 0.186 0.122 CID_154699947 | CID_154699947 | |
| 0.086 | 0.365 | 0.191 | Angiogenesis inhibitor | 0.191 0.18 CID_154699947 | CID_154699947 | |
| 0.08 | 0.363 | 0.182 | Superoxide dismutase inhibitor | 0.182 0.139 CID_154699947 | CID_154699947 | |
| 0.008 | 0.305 | 0.036 | NMDA 2D receptor antagonist | 0.036 0.011 CID_154699947 | CID_154699947 | |
| 0.011 | 0.415 | 0.218 | Cholecystokinin B agonist | 0.218 0.004 CID_154699947 | CID_154699947 | |
| 0.009 | 0.498 | 0.104 | CDC25A inhibitor | 0.104 0.025 CID_154699947 | CID_154699947 | |
| 0.003 | 0.551 | 0.111 | Cholecystokinin A agonist | 0.111 0.004 CID_154699947 | CID_154699947 | |
| 0.003 | 0.563 | 0.113 | Cholecystokinin agonist | 0.113 0.004 CID_154699947 | CID_154699947 | |
| 0.003 | 0.577 | 0.044 | Cholecystokinin A antagonist | 0.044 0.022 CID_154699947 | CID_154699947 | |
| 0.005 | 0.581 | 0.064 | Selectin antagonist | 0.064 0.046 CID_154699947 | CID_154699947 | |
| 0.009 | 0.588 | 0.216 | Diuretic | 0.216 0.039 CID_154699947 | CID_154699947 | |
| 0.018 | 0.598 | 0.272 | Angiogenesis stimulant | 0.272 0.06 CID_154699947 | CID_154699947 | |
| 0.011 | 0.678 | 0.126 | Anticoagulant | 0.126 0.104 CID_154699947 | CID_154699947 | |
| 0.004 | 0.728 | 0.075 | NMDA 2B receptor antagonist | 0.075 0.023 CID_154699947 | CID_154699947 | |
| 0.008 | 0.832 | 0.213 | Dual specificity phosphatase inhibitor | 0.213 0.049 CID_154699947 | CID_154699947 | |
| 0.006 | 0.843 | 0.215 | Dual specificity phosphatase 3 inhibitor | 0.215 0.053 CID_154699947 | CID_154699947 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |